To access deeper insights on emerging innovations, consumer shifts, and market opportunities in the GLP-1 space, download our full report today
A multicentre retrospective study of 499 patients identified ICI patients with renal cell carcinoma (RCC) in which 80 patients developed severe irAEs warranting treatment cessation, 36 of whom were able to be restarted on an ICI agent and 44 permanently discontinued
The FDA has warned about unapproved GLP-1 products sold online and has noted concerns that illegally marketed products may be counterfeit, may contain incorrect or harmful ingredients, or may contain too little, too much, or none of the claimed active ingredients
The idea is to use less than the recommended amount of the drug to experience subtle benefits, make the prescription last longer and also save money
Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: The HARMONIZE randomized clinical trial
American family physician, 96(12), 784789